Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study

Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study

Abstract Aims Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i) represent a unique class of anti‐hyperglycaemic agents for type 2 diabetes mellitus that selectively inhibit renal glucose reabsorption, thereby increasing urinary excretion of glucose. Several studies have demonstrated the cardi...

Full description

Bibliographic Details
Main Authors: Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, Pietro Mazzeo, Stefano Coiro, Shiro Ishihara, Renata Petroni, Francesco Monitillo, Marta Leone, Marco Triggiani, Chaudhry M.S. Sarwar, Hans‐Dirk Dungen, Khawaja M. Talha, Natale D. Brunetti, Javed Butler, Savina Nodari, Master Program Group on Drug Development for Heart Failure
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:ESC Heart Failure
Subjects:
Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i)
Heart failure (HF)
Cardiac structure and function
Echocardiography
Online Access:https://doi.org/10.1002/ehf2.14331

Internet

https://doi.org/10.1002/ehf2.14331

Similar Items